| Clusterin in Alzheimer’s disease: mechanisms, genetics, and lessons from other pathologies EM Foster, A Dangla-Valls, S Lovestone, EM Ribe, NJ Buckley Frontiers in neuroscience, 164, 2019 | 341 | 2019 |
| Clusterin is required for β-amyloid toxicity in human iPSC-derived neurons JP Robbins, L Perfect, EM Ribe, M Maresca, A Dangla-Valls, EM Foster, ... Frontiers in neuroscience 12, 504, 2018 | 57 | 2018 |
| Unexpectedly high levels of inverted re-insertions using paired sgRNAs for genomic deletions J Blayney, EM Foster, M Jagielowicz, M Kreuzer, M Morotti, K Reglinski, ... Methods and protocols 3 (3), 53, 2020 | 13 | 2020 |
| Glycosylated clusterin species facilitate Aβ toxicity in human neurons EM Foster, M Fernandes, A Dangla-Valls, P Hublitz, MN Pangalos, ... | 11 | 2022 |
| The use of iPSC-derived neurons to investigate the role of clusterin trafficking in Alzheimer’s disease EM Foster University of Oxford, 2021 | | 2021 |
| CRISPR/Cas9 genome editing of CLU to examine clusterin’s contribution to neurodegeneration and Alzheimer’s disease: Molecular and cell biology/neurodegeneration and neuroprotection EM Foster, EM Ribe, J Robbins, P Hublitz, M Pangalos, N Buckley, ... Alzheimer's & Dementia 16, e040292, 2020 | | 2020 |
| CRISPR/Cas9 genome editing of CLU to examine clusterin’s contribution to neurodegeneration and Alzheimer’s disease EM Foster, EMM Ribe, J Robbins, P Hublitz, M Pangalos, N Buckley, ... 2020 Alzheimer's Association International Conference, 2020 | | 2020 |
